Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00269009
Other study ID # 61-9165
Secondary ID
Status Recruiting
Phase Phase 1
First received December 22, 2005
Last updated January 10, 2007
Start date January 2006
Est. completion date February 2007

Study information

Verified date September 2006
Source Great Lakes Research Into Practice Network
Contact Annette M Sokolnicki
Phone 517/353-0772
Email annette.sokolnicki@hc.msu.edu
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The investigators want to find out if providing a Community Health Educator Referral Liaison (CHERL) helps practices help their patients change risky behaviors (tobacco use, physical inactivity, unhealthy diet, and risky drinking) by connecting patients to available services in the community or directly providing behavior change support.


Description:

What is this about? Prescription for Health (P4H) is a national initiative funded by the Robert Wood Johnson Foundation. Nine projects have been funded nationally in this second round to advance the goals of improving health behavior identification and delivery in primary care practice. Each project is conducted through a practice-based research network (PBRN). In Michigan, our PBRN is called the Great Lakes Research In Practice Network (GRIN).

What is the purpose of the CHERL project? In our study, we want to find out if providing a Community Health Educator Referral Liaison (CHERL) helps practices help their patients change risky behaviors (tobacco use, physical inactivity, unhealthy diet, and risky drinking) by connecting patients to available services in the community or directly providing behavior change support.

Primary care providers play a key roll in encouraging patients to choose healthy behaviors. However, effective behavior change requires long term follow up and support that may not be readily available within the office practice. CHERL can help provide or link to those services thus helping the healthy message promoted by the clinician to have a more powerful and lasting effect.

What is the CHERL intervention? With this funding, we will hire and train a CHERL to work with practices. The purpose of the CHERL is for him/her to help secure behavior change support for your patients either by referring to an available resource within the community or directly providing the service. This service is available to patients with or without chronic disease diagnoses (i.e, patients with diabetes, heart disease, hypertension, obesity, back pain, lung disease, or generally healthy with opportunities to change unhealthy habits).

Patients are referred to the CHERL and he/she will determine an appropriate next step for your patient – either referral to a community program or the CHERL will provide brief telephone counseling. The health care provider will receive feedback specifically on each patient referred.

In addition, some practices (consultant-enhanced) will receive additional assistance from the CHERL, as he/she serves as a consultant to the practice, helping the practice to identify systematic mechanisms for identification and referral of at risk patients to the CHERL.


Recruitment information / eligibility

Status Recruiting
Enrollment 0
Est. completion date February 2007
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients, clinicians, and their staff participating in this GRIN study.

Exclusion Criteria:

- Patients, clinicians, and their staff who are not participating in this GRIN study.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Educational/Counseling/Training


Intervention

Behavioral:
CHERL


Locations

Country Name City State
United States Genesys Health System Flint Michigan
United States MCRC Grand Rapids Michigan
United States UP Health Education Corporation Marquette Michigan

Sponsors (10)

Lead Sponsor Collaborator
Great Lakes Research Into Practice Network Agency for Healthcare Research and Quality (AHRQ), Genesee Health Plan, Genesys Health System, Grand Rapids Medical Education and Research Center for Health Professions, Greater Flint Health Coalition, Marquette General Health System, Michigan Department of Community Health, Robert Wood Johnson Foundation, Upper Peninsula Health Education Corporation;

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary outcome of interest is the referral rate for any unhealthy behavior to the CHERL with the predictor variable being referral-only versus consultant-enhanced practices.
Secondary Aim 2 of the study is to determine if the patients referred to the CHERL demonstrate health behavior improvements.
See also
  Status Clinical Trial Phase
Withdrawn NCT02432066 - Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions Phase 2
Completed NCT03960138 - Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking N/A
Recruiting NCT05030272 - Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings N/A
Completed NCT04646668 - Comparative Abuse Liability Among African American and White Smokers N/A
Completed NCT02560324 - Effect of Ramelteon on Smoking Abstinence Phase 2
Completed NCT02347605 - Medicinal Nicotine for Preventing Cue Induced Craving N/A
Terminated NCT01800500 - Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers N/A
Completed NCT01570595 - Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV Phase 1/Phase 2
Completed NCT01442753 - Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth N/A
Completed NCT01625767 - Tobacco Approach Avoidance Training for Adolescent Smokers-1 Phase 2
Completed NCT01428310 - Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke Phase 1
Active, not recruiting NCT01539525 - Screening to Augment Referral to Treatment- Project START Phase 2
Completed NCT00967005 - N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers Phase 2
Completed NCT01337817 - A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers Phase 1
Active, not recruiting NCT00751660 - Screening Methods in Finding Lung Cancer Early in Current or Former Smokers N/A
Completed NCT00790569 - Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking N/A
Completed NCT00664261 - Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking N/A
Completed NCT00134927 - A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches N/A
Completed NCT00158158 - Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2 Phase 2/Phase 3
Completed NCT00218179 - Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1 N/A